UPDATE 1-Regeneron CEO says Amgen not putting patients first in patent dispute

Jan 9 (Reuters) - Regeneron Pharmaceuticals Chief

Executive Len Schleifer on Monday ripped into Amgen Inc

for its insistence on blocking sales of a rival Regeneron

cholesterol drug while the appeals...

Read more